α and 1–β [Power / Sample Size]

posted by Yura – Belarus, 2017-12-28 07:50 (1919 d 20:46 ago) – Posting: # 18108
Views: 32,217

Hi Helmut,

❝ Although the study was performed with 28 subjects for ~81% power, the chance to get a post hoc power of ≥ 90% is ~23% and ≥ 95% is ~10%. That’s clearly not “forced BE” and none of these studies should be questioned by regulators.


You are considering the power after the study at n = 28 (which were calculated before the study: GMR=0.95, CV=0.25, β=0.80). The question is whether it is possible to carry out a study at n = 50 and will this be forced bioequivalence?
Regards

Complete thread:

UA Flag
Activity
 Admin contact
22,559 posts in 4,725 threads, 1,607 registered users;
15 visitors (0 registered, 15 guests [including 9 identified bots]).
Forum time: 05:36 CEST (Europe/Vienna)

The penalty for scientific irrelevance is, of course,
that the statistician’s work is ignored by the scientific community.    George E.P. Box

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5